Search - tctmd.com

Displaying 281 - 300 of 831

Sort: Relevancy | Date

News Daily News

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

Yael L. Maxwell

September 18, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

Presentation ESC 2018

CULPRIT-SHOCK: Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock – 1-Year Results

Presenter: Holger Thiele

August 26, 2018

News Conference News ESC 2018

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

Todd Neale

August 26, 2018

News Conference News ESC 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

Todd Neale

August 25, 2018

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

News Daily News

SCAI Updates Statement on Intracoronary Diagnostic Tools

Todd Neale

July 17, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

News Conference News SCAI 2018

Culprit Vessel-Only Interventions in Cardiogenic Shock, Acute MI Get Boost in Registry Analysis

Shelley Wood

April 26, 2018

News Daily News

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Yael L. Maxwell

April 23, 2018

Podcast TCTMD Talking Points

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock

April 18, 2018

Presentation CIT 2018

Optimal Pharmacology and PCI Strategy in STEMI & Multivessel Disease

Presenter: Ran Kornowski

March 23, 2018

Presentation CIT 2018

FFR Guided PCI in STEMI patients with Multivessel Disease

Presenter: Pieter C. Smits

March 23, 2018

Presentation CIT 2018

CULPRIT-SHOCK: A Randomized Trial of Culprit Lesion Only versus Multivessel PCI in Infarct-Related Cardiogenic Shock

Presenter: Steffen Desch

March 23, 2018

Presentation CHIP at ACC 2018

Update on PCI for LMCA and Multivessel Disease

Presenter: Gregg W. Stone

March 09, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

News Conference News CRT 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Michael O'Riordan

March 06, 2018

Advertisement

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

CULPRIT-SHOCK: Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock – 1-Year Results

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

SCAI Updates Statement on Intracoronary Diagnostic Tools

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Culprit Vessel-Only Interventions in Cardiogenic Shock, Acute MI Get Boost in Registry Analysis

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock

Optimal Pharmacology and PCI Strategy in STEMI & Multivessel Disease

FFR Guided PCI in STEMI patients with Multivessel Disease

CULPRIT-SHOCK: A Randomized Trial of Culprit Lesion Only versus Multivessel PCI in Infarct-Related Cardiogenic Shock

Update on PCI for LMCA and Multivessel Disease

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content